08.04.2016 • News

Monsanto No Longer After Large-Scale Deals

Getting back to business after the collapse of the plan to take over Swiss rival Syngenta, Monsanto’s CEO, Hugh Grant, told journalists this week the company no longer sees “large scale” M&A as a viable strategy.

Instead, he said the company plans to look to research and development, and commercial partnerships to generate growth in its crop protectant and seeds business.

Presenting Monsanto’s quarterly results, Grant said he believes the agrochemicals industry will continue to rationalize, focusing investment to the higher-return options, and this will translate into further R&D or commercial partnerships” for which we are uniquely positioned to participate.”

While the Monsanto chief did not comment on any possible deals that might be in the works, the company has been seen as exploring potential collaborations with BASF and Bayer.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read